Clasp Therapeutics

Clasp Therapeutics is focused on advancing immuno-oncology through the development of next-generation precision T cell engagers (TCEs) that target specific tumor mutations. Their innovative approach aims to enhance the immune system's ability to identify and destroy cancer cells while minimizing damage to normal tissues. The company is dedicated to... transforming patient outcomes by providing off-the-shelf immunotherapies that cater to a wide range of cancers, particularly those driven by KRas mutations. Clasp Therapeutics collaborates with partners to develop highly tumor-specific therapies, striving to make a meaningful impact on the lives of cancer patients.Read More